Filing Details
- Accession Number:
- 0001144204-19-029304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-31 18:28:44
- Reporting Period:
- 2019-05-31
- Accepted Time:
- 2019-05-31 18:28:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
352998 | Teligent Inc. | TLGT | Pharmaceutical Preparations (2834) | 010355758 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184312 | C James Gale | C/O Teligent, Inc., 105 Lincoln Avenue Buena NJ 08310 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-31 | 20,000 | $0.66 | 394,624 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 25,000 | Indirect | See footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6550 to $0.6599, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- These securities are held by Gale & Haselton Family LLC (Mr. Gale has voting and dispositive power with respect to such shares in his capacity as manager of the entity). The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.